These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 25687)
1. Inhibition of [3H]-dihydroalprenolol binding to rat cardiac membranes of various beta-blocking agents. Chenieux-Guicheney P; Dausse JP; Meyer P; Schmitt H Br J Pharmacol; 1978 May; 63(1):177-81. PubMed ID: 25687 [TBL] [Abstract][Full Text] [Related]
2. Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding. Williams LT; Jarett L; Lefkowitz RJ J Biol Chem; 1976 May; 251(10):3096-104. PubMed ID: 942608 [TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding. Chang RS; Lotti VJ Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line. Mauger JP; Worcel M Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725 [TBL] [Abstract][Full Text] [Related]
5. Identification of beta adrenergic receptors in rat hypothalamus. Caron MG; Gagne B; De Lean A Can J Biochem; 1977 Jul; 55(7):693-9. PubMed ID: 19139 [TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site. Sawutz DG; Sylvestre D; Homcy CJ J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414 [TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase. Nagatomo T; Sasaki M; Tsuchihashi H; Imai S Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011 [TBL] [Abstract][Full Text] [Related]
8. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase. Zatz M; Kebabian JW; Romero JA; Lefkowitz RJ; Axelrod J J Pharmacol Exp Ther; 1976 Mar; 196(3):714-22. PubMed ID: 4608 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol. Riva MA; Creese I Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver. Sandnes D; Westergren T; Sand TE; Sager G; Refsnes M; Christoffersen T; Jacobsen S Acta Pharmacol Toxicol (Copenh); 1984 Oct; 55(4):287-96. PubMed ID: 6150600 [TBL] [Abstract][Full Text] [Related]
11. [Characteristics of lipolytic activities in the genetically obese Zucker fatty rats--experimental study on (-)-[3H]dihydroalprenolol binding in the intact fat cells]. Matsumoto G Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1145-59. PubMed ID: 6141076 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen. Nahorski SR; Barnett DB; Howlett DR; Rugg EL Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 307(3):227-33. PubMed ID: 226895 [TBL] [Abstract][Full Text] [Related]
13. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. Caron MG; Lefkowitz RJ J Biol Chem; 1976 Apr; 251(8):2374-84. PubMed ID: 4447 [TBL] [Abstract][Full Text] [Related]
14. Identification of beta-adrenoceptors in bovine teat muscles by 3H-dihydroalprenolol binding. Roets E; Peeters G; Leysen JE Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):203-14. PubMed ID: 6091578 [TBL] [Abstract][Full Text] [Related]
15. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. Williams LT; Gore TB; Lefkowitz RJ J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086 [TBL] [Abstract][Full Text] [Related]
16. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p. Lang PH; Lemmer B J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385 [TBL] [Abstract][Full Text] [Related]
17. Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding. Alexander RW; Williams LT; Lefkowitz RJ Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1564-8. PubMed ID: 1055427 [TBL] [Abstract][Full Text] [Related]
18. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay. Asano M; Hashimoto H; Nakashima M Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species. Nahorski SR Eur J Pharmacol; 1978 Oct; 51(3):199-209. PubMed ID: 213289 [TBL] [Abstract][Full Text] [Related]
20. The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes. Baker SP; Posner P Life Sci; 1983 Aug; 33(5):459-66. PubMed ID: 6135967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]